Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-111090
Filing Date
2025-11-17
Accepted
2025-11-14 17:37:34
Documents
151
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0265278-20f_gelteq.htm   iXBRL 20-F 1977837
2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12(B) OF THE SECURITIES EXCHA ea026527801ex2-1_gelteq.htm EX-2.1 81810
3 PRODUCT DEVELOPMENT AND PROFIT SHARE AGREEMENT, DATED JULY 31, 2025, BETWEEN MEL ea026527801ex4-25_gelteq.htm EX-4.25 171580
4 CERTIFICATION ea026527801ex12-1_gelteq.htm EX-12.1 9329
5 CERTIFICATION ea026527801ex12-2_gelteq.htm EX-12.2 9764
6 CERTIFICATION ea026527801ex13-1_gelteq.htm EX-13.1 3385
7 CERTIFICATION ea026527801ex13-2_gelteq.htm EX-13.2 3404
13 GRAPHIC image_001.jpg GRAPHIC 31012
14 GRAPHIC image_002.jpg GRAPHIC 49750
15 GRAPHIC image_003.jpg GRAPHIC 5435
16 GRAPHIC image_004.jpg GRAPHIC 23588
17 GRAPHIC ex4-25_001.jpg GRAPHIC 2403
  Complete submission text file 0001213900-25-111090.txt   9435598

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE gels-20250630.xsd EX-101.SCH 146312
9 XBRL CALCULATION FILE gels-20250630_cal.xml EX-101.CAL 58186
10 XBRL DEFINITION FILE gels-20250630_def.xml EX-101.DEF 387525
11 XBRL LABEL FILE gels-20250630_lab.xml EX-101.LAB 769196
12 XBRL PRESENTATION FILE gels-20250630_pre.xml EX-101.PRE 403302
154 EXTRACTED XBRL INSTANCE DOCUMENT ea0265278-20f_gelteq_htm.xml XML 1212577
Mailing Address LEVEL 4 100 ALBERT ROAD SOUTH MELBOURNE VIC Australia
Business Address LEVEL 4 100 ALBERT ROAD SOUTH MELBOURNE VIC Australia 61390873990
Gelteq Ltd (Filer) CIK: 0001920092 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-42373 | Film No.: 251488433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)